- Home
- CDTX vs AUDC Comparison
CDTX vs AUDC Comparison
Compare CDTX & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- AUDC
- Stock Information
- Founded
- CDTX 2012
- AUDC 1992
- Country
- CDTX United States
- AUDC Israel
- Employees
- CDTX N/A
- AUDC N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- AUDC Telecommunications Equipment
- Sector
- CDTX Health Care
- AUDC Utilities
- Exchange
- CDTX Nasdaq
- AUDC Nasdaq
- Market Cap
- CDTX 980.1M
- AUDC 282.4M
- IPO Year
- CDTX 2015
- AUDC 1999
- Fundamental
- Price
- CDTX $61.93
- AUDC $10.04
- Analyst Decision
- CDTX Strong Buy
- AUDC Buy
- Analyst Count
- CDTX 11
- AUDC 3
- Target Price
- CDTX $52.11
- AUDC $11.67
- AVG Volume (30 Days)
- CDTX 730.2K
- AUDC 176.2K
- Earning Date
- CDTX 08-07-2025
- AUDC 07-29-2025
- Dividend Yield
- CDTX N/A
- AUDC 3.57%
- EPS Growth
- CDTX N/A
- AUDC 3.22
- EPS
- CDTX N/A
- AUDC 0.46
- Revenue
- CDTX $302,000.00
- AUDC $243,249,000.00
- Revenue This Year
- CDTX N/A
- AUDC $1.54
- Revenue Next Year
- CDTX N/A
- AUDC $1.41
- P/E Ratio
- CDTX N/A
- AUDC $22.69
- Revenue Growth
- CDTX N/A
- AUDC N/A
- 52 Week Low
- CDTX $10.14
- AUDC $7.70
- 52 Week High
- CDTX $66.95
- AUDC $12.72
- Technical
- Relative Strength Index (RSI)
- CDTX 69.24
- AUDC 51.49
- Support Level
- CDTX $60.71
- AUDC $10.18
- Resistance Level
- CDTX $66.95
- AUDC $11.50
- Average True Range (ATR)
- CDTX 4.30
- AUDC 0.56
- MACD
- CDTX -0.13
- AUDC 0.03
- Stochastic Oscillator
- CDTX 73.01
- AUDC 44.06
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.